Related Experiment Video
Updated: Apr 20, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia
Insights
Essential thrombocythemia patients with high platelet counts can safely undergo off-pump surgery. Pre-operative reduction of platelet count with hydroxycarbamide is crucial for successful outcomes.
Area of Science:
- Cardiology
- Hematology
- Oncology
Background:
- Essential thrombocythemia is a myeloproliferative disorder associated with frequent thrombotic complications.
- Patients with essential thrombocythemia often present with comorbidities like coronary artery disease.
Observation:
- A 71-year-old male with severe coronary artery disease, cerebral ischemia, and erythromelalgia had a platelet count of 1,486 ×10(3)/μL.
- The patient underwent successful off-pump myocardial revascularization after platelet count reduction with hydroxycarbamide.
Findings:
- Off-pump cardiopulmonary bypass is a safe surgical option for high-risk essential thrombocythemia patients.
- Pre-operative platelet count reduction using hydroxycarbamide is vital for surgical success.
Implications:
- This case highlights a safe anesthetic and surgical approach for essential thrombocythemia patients undergoing cardiac surgery.
- Careful management of antiplatelet and anticoagulant therapies is critical for optimizing surgical outcomes in these patients.
Abstract:
Essential thrombocythemia is a rare type of myeloproliferative disorder. Cerebral, myocardial, and peripheral thrombosis are all frequent complications of the disease. A 71-year-old man presented with severe coronary artery disease, associated with cerebral vascular ischemic changes and erythromelalgia. His platelet count was 1,486 ×10(3)/μL. The patient underwent successful myocardial revascularization by means of an off-pump technique after his platelet count had been reduced by hydroxycarbamide administration. We conclude that the use of off-pump cardiopulmonary bypass in high-risk patients with essential thrombocythemia is safe. Reducing platelet count via the administration of hydroxycarbamide and the careful balancing of antiplatelets and anticoagulants is crucial in determining the outcome of surgery.
More Related Videos
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview

